Curcumin: a Polyphenol with Molecular Targets for Cancer Control

Area of Science:

• Phytochemistry
• Pharmacology
• Oncology

Background:

• Curcumin is a polyphenol derived from Curcuma longa (turmeric).
• It has a history of use in Ayurvedic medicine for various ailments.
• Curcumin possesses a wide range of biological activities, including anti-inflammatory, antioxidant, and anti-cancer effects.

Purpose of the Study:

• To review the anticancer activities of curcumin.
• To identify the molecular targets of curcumin in cancer treatment.
• To explore curcumin's potential in suppressing cancer initiation and progression.

Main Methods:

• Literature review of studies on curcumin's anticancer properties.
• Analysis of molecular mechanisms underlying curcumin's anti-cancer effects.
• Identification of key targets regulated by curcumin in cancer cells.

Main Results:

• Curcumin demonstrates anti-cancer effects by inhibiting cancer initiation and progression.
• Its anticancer activity is attributed to the negative regulation of inflammatory cytokines, transcription factors, protein kinases, reactive oxygen species (ROS), and oncogenes.
• The review highlights various molecular targets through which curcumin exerts its anti-cancer effects.

Conclusions:

• Curcumin shows significant potential as an anti-cancer agent.
• Understanding curcumin's molecular targets is crucial for developing effective cancer therapies.
• Further research into curcumin's therapeutic applications in oncology is warranted.